Process improvements and in-person monitoring help U.S. pharmaceutical company achieve on time for Phase III clinical trials
Impact Pharmaceutical Services
SEPTEMBER 20, 2023
pharmaceutical company to oversee a 6 month, DS manufacturing as Person-In- Plant (PIP) and assist with preparation of associated submission documents related to Phase III clinical trial batches. Download The Case Study The post Process improvements and in-person monitoring help U.S.
40 
Let's personalize your content